Both in Pharmaceuticals
Cytokinetics vs Spyre Therapeutics
Over the past year CYTK returned −0.9% and SYRE returned +294.8%; their daily moves had a correlation of 0.33.
CYTK −0.9% SYRE +294.8%Growth of $1, one year, split-adjusted
| Metric | CYTK | SYRE |
|---|---|---|
| Price | $62.99 | $96.56 |
| Market cap | $8.76B | $9.02B |
| Today | −0.51% | −2.43% |
| 1 month | −4.0% | +7.4% |
| 6 months | −0.6% | +39.1% |
| Year to date | −0.9% | +194.7% |
| 1 year | +1.6% | +305.2% |
| Revenue growth (YoY) | −57.1% | — |
| Gross margin | 90.5% | — |
| Net margin | −694.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 129.4× | — |
| Net cash | $18.6M | $1.15B |
| Dividend yield | — | — |
| Volatility (60d) | 33.6% | 58.7% |
| Short % of float | 15.4% | 15.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).